 Nolan Wessell
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgeons | 1 | 2021 | 236 | 0.600 |
Why?
| | Internal Fixators | 1 | 2018 | 39 | 0.590 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 72 | 0.580 |
Why?
| | Scoliosis | 1 | 2018 | 181 | 0.500 |
Why?
| | Arthroplasty, Replacement, Hip | 5 | 2018 | 109 | 0.490 |
Why?
| | Telemedicine | 1 | 2021 | 665 | 0.440 |
Why?
| | Arthroplasty, Replacement, Knee | 3 | 2016 | 246 | 0.290 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2018 | 486 | 0.210 |
Why?
| | Pedicle Screws | 1 | 2022 | 15 | 0.200 |
Why?
| | Surgery, Computer-Assisted | 1 | 2022 | 63 | 0.190 |
Why?
| | Hip Fractures | 2 | 2018 | 75 | 0.180 |
Why?
| | Physical Examination | 1 | 2021 | 221 | 0.180 |
Why?
| | Spinal Fusion | 1 | 2022 | 213 | 0.170 |
Why?
| | Mortality | 2 | 2018 | 287 | 0.170 |
Why?
| | Prostheses and Implants | 1 | 2020 | 139 | 0.160 |
Why?
| | Blood Loss, Surgical | 2 | 2016 | 86 | 0.160 |
Why?
| | Spine | 1 | 2020 | 139 | 0.150 |
Why?
| | Femoral Neck Fractures | 1 | 2018 | 22 | 0.150 |
Why?
| | Thinness | 1 | 2018 | 87 | 0.150 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2017 | 2 | 0.140 |
Why?
| | Granuloma, Plasma Cell | 1 | 2017 | 12 | 0.140 |
Why?
| | Metals | 1 | 2017 | 107 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 278 | 0.130 |
Why?
| | Hip Joint | 1 | 2017 | 131 | 0.130 |
Why?
| | Radiography | 1 | 2018 | 827 | 0.120 |
Why?
| | Body Mass Index | 3 | 2018 | 1967 | 0.120 |
Why?
| | Enoxaparin | 1 | 2015 | 52 | 0.120 |
Why?
| | Disease Management | 1 | 2018 | 563 | 0.110 |
Why?
| | Transfusion Reaction | 1 | 2014 | 66 | 0.110 |
Why?
| | Blood Transfusion | 1 | 2016 | 276 | 0.110 |
Why?
| | Ultrasonography | 1 | 2017 | 636 | 0.110 |
Why?
| | Rivaroxaban | 1 | 2015 | 211 | 0.110 |
Why?
| | Prospective Studies | 2 | 2021 | 6232 | 0.110 |
Why?
| | Aged | 6 | 2021 | 19119 | 0.100 |
Why?
| | Retrospective Studies | 6 | 2018 | 12547 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2015 | 231 | 0.100 |
Why?
| | Anticoagulants | 1 | 2015 | 546 | 0.090 |
Why?
| | Male | 7 | 2021 | 55730 | 0.090 |
Why?
| | Middle Aged | 4 | 2021 | 26827 | 0.070 |
Why?
| | Humans | 10 | 2022 | 115039 | 0.070 |
Why?
| | Fracture Fixation, Internal | 2 | 2018 | 195 | 0.070 |
Why?
| | United States | 1 | 2021 | 12224 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1080 | 0.060 |
Why?
| | Female | 6 | 2021 | 59611 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2018 | 1435 | 0.060 |
Why?
| | Comorbidity | 2 | 2018 | 1457 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2014 | 2150 | 0.060 |
Why?
| | Surgical Wound Infection | 2 | 2016 | 247 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1721 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 212 | 0.040 |
Why?
| | Adult | 1 | 2021 | 30655 | 0.040 |
Why?
| | Steel | 1 | 2020 | 7 | 0.040 |
Why?
| | Corrosion | 1 | 2020 | 15 | 0.040 |
Why?
| | Alloys | 1 | 2020 | 30 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2020 | 192 | 0.040 |
Why?
| | Titanium | 1 | 2020 | 73 | 0.040 |
Why?
| | Age Factors | 2 | 2018 | 2894 | 0.040 |
Why?
| | Child | 1 | 2018 | 18407 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2022 | 538 | 0.040 |
Why?
| | Surface Properties | 1 | 2020 | 387 | 0.040 |
Why?
| | Open Fracture Reduction | 1 | 2018 | 24 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 292 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2018 | 147 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2018 | 814 | 0.030 |
Why?
| | Platelet Transfusion | 1 | 2016 | 65 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2016 | 144 | 0.030 |
Why?
| | Operative Time | 1 | 2014 | 106 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 184 | 0.030 |
Why?
| | Factor Xa Inhibitors | 1 | 2015 | 138 | 0.030 |
Why?
| | Risk Factors | 2 | 2018 | 8642 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2341 | 0.030 |
Why?
| | Creatinine | 1 | 2014 | 425 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 233 | 0.030 |
Why?
| | Overweight | 1 | 2016 | 474 | 0.030 |
Why?
| | Hemoglobins | 1 | 2014 | 315 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 608 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3015 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2551 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2255 | 0.020 |
Why?
| | Hemorrhage | 1 | 2015 | 618 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 4904 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4420 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6357 | 0.020 |
Why?
| | Obesity | 1 | 2016 | 2524 | 0.010 |
Why?
|
|
Wessell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|